Literature DB >> 15186621

Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with Graves' ophthalmopathy.

Michele Marinó, Eugenia Morabito, Maurizia Rossana Brunetto, Luigi Bartalena, Aldo Pinchera, Claudio Marocci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15186621     DOI： 10.1089/105072504774193276

Source DB:  PubMed          Journal:  Thyroid        ISSN： 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  33 in total

Review 1.  Pharmacological treatments for thyroid eye disease.

Authors:  Sara P Modjtahedi; Bobeck S Modjtahedi; Ahmad M Mansury; Dinesh Selva; Raymond S Douglas; Robert A Goldberg; Igal Leibovitch
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 2.  An update on medical management of Graves' ophthalmopathy.

Authors:  L Bartalena; C Marcocci; M L Tanda; E Piantanida; A Lai; M Marinò; A Pinchera
Journal:  J Endocrinol Invest       Date:  2005-05       Impact factor: 4.256

3.  Quercetin decreases proliferation of orbital fibroblasts and their release of hyaluronic acid.

Authors:  S Lisi; R Botta; M Lemmi; S Sellari-Franceschini; M A Altea; E Sisti; G Casini; M Nardi; C Marcocci; A Pinchera; M Marinò
Journal:  J Endocrinol Invest       Date:  2010-10-27       Impact factor: 4.256

4.  Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapy.

Authors:  E Sisti; F Menconi; M Leo; M A Profilo; T Mautone; B Mazzi; R Rocchi; F Latrofa; M Nardi; P Vitti; C Marcocci; M Marinò
Journal:  J Endocrinol Invest       Date:  2015-01-18       Impact factor: 4.256

5.  Delivery of anti-inflammatory peptides from hollow PEGylated poly(NIPAM) nanoparticles reduces inflammation in an ex vivo osteoarthritis model.

Authors:  James McMasters; Scott Poh; Jenny B Lin; Alyssa Panitch
Journal:  J Control Release       Date:  2017-05-08       Impact factor: 9.776

Review 6.  The evaluation and treatment of graves ophthalmopathy.

Authors:  Marius N Stan; James A Garrity; Rebecca S Bahn
Journal:  Med Clin North Am       Date:  2012-02-22       Impact factor: 5.456

Review 7.  Graves' orbitopathy: imperfect treatments for a rare disease.

Authors:  Luigi Bartalena
Journal:  Eur Thyroid J       Date:  2013-11-20

8.  Comprehensive analysis of patients with neuromyelitis optica spectrum disorder (NMOSD) combined with chronic hepatitis B (CHB) infection and seropositive for anti-aquaporin-4 antibody.

Authors:  Jia Liu; Li Xu; Zhuo-Lin Chen; Min Li; Huan Yi; Fu-Hua Peng
Journal:  Bosn J Basic Med Sci       Date:  2018-02-20       Impact factor: 3.363

9.  Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathy.

Authors:  E Sabini; E Sisti; B Coco; M Leo; I Ionni; F Menconi; M A Profilo; B Mazzi; R Rocchi; F Latrofa; P Vitti; M Brunetto; C Marcocci; M Marinò
Journal:  J Endocrinol Invest       Date:  2016-07-27       Impact factor: 4.256

10.  Update on thyroid eye disease and management.

Authors:  Erick D Bothun; Ryan A Scheurer; Andrew R Harrison; Michael S Lee
Journal:  Clin Ophthalmol       Date:  2009-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.